BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10425273)

  • 21. p53 at codon 72 polymorphism, human papillomavirus infection and cervical lesions: a cross-sectional study from northeastern Italy.
    Comar M; Molin GD; Guaschino S; Campello C
    Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):210-4. PubMed ID: 15140517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients.
    Bau DT; Tsai MH; Lo YL; Hsu CM; Tsai Y; Lee CC; Tsai FJ
    Anticancer Res; 2007; 27(3B):1559-64. PubMed ID: 17595776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
    Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G
    Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms of GSTM1, p21, p53 and HPV infection with cervical cancer in Korean women.
    Lee SA; Kim JW; Roh JW; Choi JY; Lee KM; Yoo KY; Song YS; Kang D
    Gynecol Oncol; 2004 Apr; 93(1):14-8. PubMed ID: 15047208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy.
    Tenti P; Vesentini N; Rondo Spaudo M; Zappatore R; Migliora P; Carnevali L; Ranzani GN
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):435-8. PubMed ID: 10794489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation between P53 codon 72 polymorphism and tumorigenesis of cervical cancer].
    Li CY; Liu JH; Huang BJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1396-9. PubMed ID: 15566643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India.
    Katiyar S; Thelma BK; Murthy NS; Hedau S; Jain N; Gopalkrishna V; Husain SA; Das BC
    Mol Cell Biochem; 2003 Oct; 252(1-2):117-24. PubMed ID: 14577584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma.
    Boltze C; Roessner A; Landt O; Szibor R; Peters B; Schneider-Stock R
    Int J Oncol; 2002 Nov; 21(5):1151-4. PubMed ID: 12370767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPV 16-E6-mediated degradation of intrinsic p53 is compensated by upregulation of p53 gene expression in normal cervical keratinocytes.
    Kawamata Y; Mitsuhashi A; Unno Y; Kado S; Shino Y; Uesugi K; Eguchi O; Ishii J; Seki K; Sekiya S; Shirasawa H
    Int J Oncol; 2002 Sep; 21(3):561-7. PubMed ID: 12168100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TP53 polymorphism, HPV infection, and risk of cervical cancer.
    Klug SJ; Wilmotte R; Santos C; Almonte M; Herrero R; Guerrero I; Caceres E; Peixoto-Guimaraes D; Lenoir G; Hainaut P; Walboomers JM; Muñoz N
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1009-12. PubMed ID: 11535556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas.
    Andersson S; Rylander E; Strand A; Sällström J; Wilander E
    Br J Cancer; 2001 Oct; 85(8):1153-6. PubMed ID: 11710828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 codon 72 polymorphism as a risk factor in the development of breast cancer.
    Papadakis EN; Dokianakis DN; Spandidos DA
    Mol Cell Biol Res Commun; 2000 Jun; 3(6):389-92. PubMed ID: 11032762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer.
    Lee JM; Shun CT; Wu MT; Chen YY; Yang SY; Hung HI; Chen JS; Hsu HH; Huang PM; Kuo SW; Lee YC
    Mutat Res; 2006 Feb; 594(1-2):181-8. PubMed ID: 16318864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 codon 72 polymorphism in cervical cancer patients and healthy women from Poland.
    Dybikowska A; Dettlaff A; Konopa K; Podhajska A
    Acta Biochim Pol; 2000; 47(4):1179-82. PubMed ID: 11996107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is there a biological plausability for p53 codon 72 polymorphism influence on cervical cancer development?
    Sousa H; Santos AM; Pinto D; Medeiros R
    Acta Med Port; 2011; 24(1):127-34. PubMed ID: 21672450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P53 codon 72 genotypes in colon cancer. Association with human papillomavirus infection.
    Sayhan N; Yazici H; Budak M; Bitisik O; Dalay N
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):25-34. PubMed ID: 11458982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer.
    Hu Y; McDermott MP; Ahrendt SA
    Clin Cancer Res; 2005 Apr; 11(7):2502-9. PubMed ID: 15814626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TP53 codon 72 polymorphism and risk for cervical cancer in Portugal.
    Santos AM; Sousa H; Catarino R; Pinto D; Pereira D; Vasconcelos A; Matos A; Lopes C; Medeiros R
    Cancer Genet Cytogenet; 2005 Jun; 159(2):143-7. PubMed ID: 15899386
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 polymorphism and risk of cervical cancer.
    Hildesheim A; Schiffman M; Brinton LA; Fraumeni JF; Herrero R; Bratti MC; Schwartz P; Mortel R; Barnes W; Greenberg M; McGowan L; Scott DR; Martin M; Herrera JE; Carrington M
    Nature; 1998 Dec; 396(6711):531-2. PubMed ID: 9859989
    [No Abstract]   [Full Text] [Related]  

  • 40. The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis.
    Buller RE; Sood A; Fullenkamp C; Sorosky J; Powills K; Anderson B
    Cancer Gene Ther; 1997; 4(4):239-45. PubMed ID: 9253509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.